Format

Send to

Choose Destination
Cornea. 2018 Feb;37(2):248-251. doi: 10.1097/ICO.0000000000001438.

Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities.

Author information

1
Cornea Service and Boston Keratoprosthesis Laboratory, Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute, Harvard Medical School, Boston, MA.

Abstract

PURPOSE:

To propose a new treatment paradigm for chemical burns to the eye - in the acute and chronic phases.

METHODS:

Recent laboratory and clinical data on the biology and treatment of chemical burns are analyzed.

RESULTS:

Corneal blindness from chemical burns can now be successfully treated with a keratoprosthesis, on immediate and intermediate bases. Long term outcomes, however, are hampered by early retinal damage causing glaucoma. New data suggest that rapid diffusion of inflammatory cytokines posteriorly (TNF-α, etc) can severely damage the ganglion cells. Prompt anti-TNF-α treatment is markedly neuroprotective. Long term profound reduction of the intraocular pressure is also vital.

CONCLUSION:

A new regimen, in addition to standard treatment, for severe chemical burns is proposed. This involves tumor necrosis factor alpha (TNF-α) inhibition promptly after the accident (primarily for retinal neuroprotection), prophylactic maximal lowering of the intraocular pressure (starting immediately), and keratoprosthesis implantation in a later quiet state.

PMID:
29135604
DOI:
10.1097/ICO.0000000000001438
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center